| Month |
Description |
|
December 2007
|
More on Limits for API Manufacture
|
|
November 2007
|
Measuring Residues of Volatile Solvents?
|
|
October 2007
|
Downsides to TOC?
|
|
September 2007
|
TOC Analytical Method Validation
|
|
August 2007
|
Master Plans vs. Policies
|
|
July 2007
|
Spiking Amounts for Sampling Recovery Studies
|
|
June 2007
|
Issues in Campaigns
|
|
May 2007
|
Revisiting Medically Safe Limits
|
|
April 2007
|
Limits for Bulk Biotech Manufacture – Part 2
|
|
March 2007
|
Limits for Bulk Biotech Manufacture – Part 1
|
|
February 2007
|
Microbiological Test Method Validation?
|
|
January 2007
|
Dealing with Deviations in the CEHT
|